For example, biomarker panels consisting of 3–5 top metabolites and proteins selected by the RF showed superior performance compared to the currently used single marker Prostate Specific Antigen in predicting the progression of prostate cancer at different stages27. The gene discussed is KLK3; the disease is Familial prostate cancer.